Endo UV Tech has officially completed its audited financial statements for the fiscal years 2021 and 2022. This action underscores the company's commitment to transparency and compliance with financial regulations.
Read MoreEndo UV Tech is proud to announce that our patent for "Device and method for dilation of a tubular anatomical structure" has been approved by the United States Patent and Trademark Office. This patent, numbered 11,446,089, covers our innovative technology for the dilation of tubular structures within the body, such as blood vessels and the respiratory system.
Read MoreEndo UV Tech, a leading innovator in medical technology, is pleased to announce the filing of a new United States patent application for a device and method for the dilation of a tubular anatomical structure. The application, titled "Device and Method for Dilation of a Tubular Anatomical Structure," is a divisional application with serial number 17/871,670, and was filed on July 22, 2022.
Read MoreEndo UV Tech is pleased to announce that we have filed a patent application on October 22nd, 2021 for a groundbreaking new device and method for dilation of a tubular anatomical structure.
Read MorePhotothrombotics, a leading provider of medical technologies, announced today that it is changing its name to Endo UV Tech effective immediately.
Read More